CRAD B C-RAD AB

C-RAD publishes outcome of Employee Warrant Program 2018/2021

C-RAD publishes outcome of Employee Warrant Program 2018/2021

C-RAD has launched a warrant program for its employees. All warrants that were offered to current employees were subscribed for.

The Annual Shareholder Meeting decided in May 2018 to issue 100,000 warrants for the purpose of using them as part of an employee incentive program for C-RAD AB. 90,000 warrants were initially offered to employees and 10,000 were issued to C-RAD Positioning AB, with permission for these to be transferred on one or more occasions to current or future employees.

Current employees of the entire C-RAD group signed up for a total of 90,000 warrants or 100% of the allotted amount. Members of the management team of C-RAD AB and C-RAD Positioning, together with key employees, have signed up for 72,000 warrants.

C-RAD will not issue new press releases if further warrants are offered and signed up for within this warrant program.

“This result speaks very positively for the company and its team,” says Tim Thurn, CEO of C-RAD. “The commitment as well as the expectations that the management team and employees have regarding the development of the company can be visualized by the interest they have shown in the warrant program. This is an excellent mechanism for aligning the interests of our employees with those of our shareholders.”

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit -rad.com

For further information:

Tim Thurn, CEO C-RAD AB, Phone , Email

The information was submitted for publication at 08:30 CEST on June 19, 2018.

Attachment

EN
19/06/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on C-RAD AB

C-Rad AB: 1 director

A director at C-Rad AB bought 8,000 shares at 32.000SEK and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...

Erik Cassel
  • Erik Cassel

C-RAD AB - Resilient despite weaker end markets

Exceptional Q3 sales and EBIT, but orders came in weak We cut ’24e EBIT by 3% on end-market weakness Fair value range of SEK 45-95/share

Erik Cassel
  • Erik Cassel

Sector Fast Comment - Hospital data update

Better hospital margins in August Congress passed supportive spending bill Small positive for companies with capex exposure

Erik Cassel ... (+2)
  • Erik Cassel
  • Jakob Lembke

C-RAD AB - Record heat on orders beat

Remarkable order intake 35% better than ABGSCe ‘23e EBIT up 8% and ‘24e up 4% Fair value range of SEK 45-95/share

ResearchPool Subscriptions

Get the most out of your insights

Get in touch